S. Pessa

534 total citations
5 papers, 416 citations indexed

About

S. Pessa is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Pessa has authored 5 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Pessa's work include Cancer therapeutics and mechanisms (2 papers), Neutropenia and Cancer Infections (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). S. Pessa is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Neutropenia and Cancer Infections (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). S. Pessa collaborates with scholars based in Italy and Brazil. S. Pessa's co-authors include Giuseppe Toffoli, Angela Buonadonna, Erika Cecchin, Mario D’Andrea, M. Boccalon, Giuseppe Corona, S. Frustaci, Enzo Galligioni, Salvatore Bonura and Paolo Sandri and has published in prestigious journals such as Journal of Clinical Oncology and British Journal of Radiology.

In The Last Decade

S. Pessa

5 papers receiving 407 citations

Peers

S. Pessa

ONCOL

MB

PHARM

PRM

PPCH

Michael Andria United States

Martin A. Graham United States

Niels de Vries Netherlands

Sarah Troutman United States

George Cusatis United States

W. Messersmith United States

Ekaphop Sirachainan Thailand

Miguel A. Villalona United States

Gyo Asai Japan

Carin A.T.C. Lunenburg Netherlands

Michael Andria United States

S. Pessa

283 ×0.9

ONCOL

168 ×0.6

MB

54 ×0.9

PHARM

49 ×0.9

PRM

47 ×1.0

PPCH

Citations per year, relative to S. Pessa S. Pessa (= 1×) peers Michael Andria

Countries citing papers authored by S. Pessa

Since Specialization

Citations

This map shows the geographic impact of S. Pessa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pessa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pessa more than expected).

Fields of papers citing papers by S. Pessa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pessa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pessa. The network helps show where S. Pessa may publish in the future.

Co-authorship network of co-authors of S. Pessa

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pessa. A scholar is included among the top collaborators of S. Pessa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pessa. S. Pessa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Toffoli, Giuseppe, Erika Cecchin, Mario D’Andrea, et al.. (2009). Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 28(5). 866–871. 130 indexed citations

2.

Chammas, Maria Cristina, et al.. (2007). Reference values for Doppler ultrasound parameters of the thyroid in a healthy iodine-non-deficient population. British Journal of Radiology. 80(956). 625–630. 18 indexed citations

3.

Toffoli, Giuseppe, Erika Cecchin, Giuseppe Corona, et al.. (2006). The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 24(19). 3061–3068. 263 indexed citations

4.

Bidoli, Paolo, Diego Cortinovis, L. Isa, et al.. (2005). Preliminary results of a randomized phase II three-arm, multicentric study of carboplatin + gemcitabine (CBDCA + GEM), or oxaliplatin (L-OHP) + GEM, or sequential CBDCA + GEM→ docetaxel (DCT) + GEM in chemo-naive patients (pts) with advanced/metastatic non small cell lung cancer (NSCLC). Journal of Clinical Oncology. 23(16_suppl). 7118–7118. 4 indexed citations

5.

Sava, Teodoro, S. Pessa, A. Perin, et al.. (2004). Nonseminomatous germ cell testicular tumors clinical stage II: Retroperitoneal lymph node dissection, chemotherapy or both?. Journal of Clinical Oncology. 22(14_suppl). 4746–4746. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact